Kee Song Bio-Technology Holdings Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 577.339 million compared to TWD 721.046 million a year ago. Operating income was TWD 24.599 million compared to operating loss of TWD 45.958 million a year ago. Net income was TWD 16.420 million compared to net loss of TWD 56.852 million a year ago. Basic earnings per share from continuing operations was TWD 0.45 compared to basic loss per share from continuing operations of TWD 1.54 a year ago. Diluted earnings per share from continuing operations was TWD 0.4 compared to diluted loss per share from continuing operations of TWD 1.54 a year ago.